x(1125).png?1144971504 "Spain: Myelodysplastic Syndrome Mortality, by gender"){kind=logo}
| Year | Men | Women |
|---|---|---|
| 2022 | 658 | 468 |
| 2021 | 634 | 484 |
| 2020 | 702 | 471 |
| 2019 | 619 | 511 |
| 2018 | 656 | 486 |
| 2017 | 707 | 498 |
| 2016 | 618 | 518 |
| 2015 | 564 | 517 |
| 2014 | 561 | 454 |
| 2013 | 583 | 454 |
| 2012 | 567 | 415 |
| 2011 | 517 | 387 |
| 2010 | 490 | 378 |
| 2009 | 461 | 382 |
| 2008 | 438 | 340 |
| 2007 | 436 | 326 |
| 2006 | 459 | 294 |
| 2005 | 463 | 347 |
- Region: Spain
- Time period: 2005 to 2022
- Published: Feb 2024
Data Analysis and Insights
Trend in Deaths Among Men
Men have experienced a fluctuating yet overall increasing trend in deaths due to myelodysplastic syndrome in Spain, with the lowest recorded number being 438 deaths in 2008 and the highest 707 deaths in 2017. The numbers reveal a significant increase of 269 deaths over this period, indicating a growing impact of the disease on the male population.Trend in Deaths Among Women
Women have shown a more stable pattern in mortality rates from myelodysplastic syndrome, with a gradual increase from 294 deaths in 2006 to 517 deaths in 2015, followed by a slight fluctuation. The peak for women was observed in 2015 and 2016, each with over 500 deaths, highlighting a critical period for female health concern related to this syndrome.Gender Disparity in Mortality
Throughout the years 2005-2022, men consistently reported higher numbers of deaths from myelodysplastic syndrome than women, with a notable difference reaching up to 209 more deaths in men than women in 2017. This disparity underscores a significant gender-based difference in the impact of the disease.Yearly Variability and Peak Incidents
The data exhibits noticeable yearly fluctuations in deaths among both genders, with 2017 marking the year of maximum deaths for men (707) and 2015 and 2016 for women (with over 500 deaths each). These variations suggest the influence of external factors or possibly changes in diagnosis or treatment efficacy over time.Long-term Growth in Mortality Rates
Over the 18-year span from 2005 to 2022, there has been a general upward trend in mortality from myelodysplastic syndrome for both men and women, indicating an increasing burden of the disease in Spain. The cumulative increase highlights the need for enhanced medical and policy attention towards this condition.Comparison with the Earliest and Latest Recorded Data
Comparing the earliest (2005) and the latest data points (2022), there has been an increase of 42.11% in male deaths and 34.87% in female deaths. This comparison showcases a significant rise in fatalities over nearly two decades, emphasizing the growing challenge myelodysplastic syndrome poses to public health.Overall Mortality Increase
The total number of deaths from myelodysplastic syndrome has risen from 810 in 2005 to 1,126 in 2022, marking an overall increase of 39%. This comprehensive growth reflects an escalating health concern that requires ongoing research and improved treatment strategies.Frequently Asked Questions
What is the trend in deaths due to myelodysplastic syndrome among men in Spain?
There is a fluctuating yet overall increasing trend, from 438 deaths in 2008 to 707 deaths in 2017, representing a significant increase of 269 deaths.
What pattern do female mortality rates from this syndrome show?
For women, there's a gradual increase from 294 deaths in 2006 to 517 deaths in 2015, with a peak observed in 2015 and 2016 each with over 500 deaths.
Is there a gender disparity in mortality from myelodysplastic syndrome?
Yes, men consistently reported higher numbers of deaths than women, with a notable difference of up to 209 more deaths in men than women in 2017.
Terms and Definitions
Myelodysplastic Syndromes are a group of diverse bone marrow disorders where the bone marrow does not produce enough healthy blood cells. Symptoms include fatigue, shortness of breath, unusual bleeding, or frequent infections due to the deficiency of red or white blood cells, or platelets.
Mortality refers to the state of being subject to death. In the context of a medical study or statistical report, it often relates to the number of deaths in a specific group or population, usually expressed as a mortality rate.
Bone marrow is the soft, spongy tissue inside bones that produces blood cells. In MDS, the bone marrow is dysplastic, which means it has abnormal cells and has trouble producing healthy blood cells.
Hematology is the branch of medicine concerned with the study of blood, blood-forming organs, and diseases of the blood. Understanding its principles is key to analyzing MDS's impact and mortality rates.
Hematopoietic stem cells are cells located in the bone marrow that create all new blood cells. In Myelodysplastic Syndromes, these stem cells do not mature into healthy blood cells.
Incidence rate, in epidemiology, is a measure of the probability of occurrence of a given medical condition in a population within a specified period of time.
A prevalence rate is a statistical concept referring to the total number of cases of a disease in a population at a specific time. In this case, it would refer to how widespread MDS is in the population under study.
All statistics
Related statistics
France: Infant Mortality Rate, by year
x(1125).png "France: Infant Mortality Rate, by year"){kind=logo}
Infant mortality rate in France is a measure of the number of deaths of infants under one year old in a given year per 1,000 live births in the same year.
Read more »
Read more »
All topics
Related topics
Cancer
Cancer is a prevalent disease worldwide, affecting millions of people with different types including breast, lung, prostate, and colorectal cancer, among others. Read more »